De Lemos et al. [32] showed that elevated circulating MCP-1 levels are associated with worse long-term outcomes in patients with acute coronary syndrome, including increased risk of death or myocardial infarction at 10 months of follow-up. Here, CCL2 is linked to acute coronary syndrome.